Jeffrey S. Mathiesen

Overview

Jeffrey S. Mathiesen received an average of $981K in total compensation, including $302K in salary, at HELIUS MEDICAL TECHNOLOGIES from 2021 to 2023. Jeffrey Mathiesen also received an average of $970K at NeuroBo Pharmaceuticals between 2015 and 2016.

Source: SEC filings on May 31, 2024, April 21, 2023, and April 6, 2017.

Related executives

We found 19 more executives who work or worked at HELIUS MEDICAL TECHNOLOGIES and NeuroBo Pharmaceuticals.

Dane Andreeff

HELIUS MEDICAL TECHNOLOGIES

Chief Executive Officer

Antonella Pelt

HELIUS MEDICAL TECHNOLOGIES

Chief Medical Officer

Hyung Kim

NeuroBo Pharmaceuticals

Chief Executive Officer

Joseph Hooker

NeuroBo Pharmaceuticals

Chief Executive Officer

Marshall Woodworth

NeuroBo Pharmaceuticals

Chief Financial Officer

Gil Price

NeuroBo Pharmaceuticals

Chief Executive Officer

Ben Price

NeuroBo Pharmaceuticals

Chief Executive Officer

Richard Kang

NeuroBo Pharmaceuticals

Chief Executive Officer

News

You may also like